Lung Cancer | Tumor

Incredible Hero Without A Cape

July 3rd 2021, 3:00pm


"Although Carolyn loved her role as a navigator, she realized she could help patients with lung cancer with a screening program to help with earlier detection."

The Journey to Personalized Cancer Vaccines

June 24th 2021, 3:00pm


In this episode of the “CURE® Talks Cancer” podcast, Dr. Thomas Marron of the Tisch Cancer Institute and Icahn School of Medicine at Mount Sinai in New York discusses the exciting future of cancer vaccines.

Molecular Testing in Thyroid Cancer: Interpreting Results

June 23rd 2021, 2:06pm


Lori J. Wirth, MD, describes what information she looks for from results of molecular testing that help inform treatment for her patients with thyroid cancer.

Molecular Testing and Shared Decision-Making

June 23rd 2021, 1:58pm


Andrea Ferris, of the LUNGevity Foundation, explains why shared decision-making is important when recommending molecular testing to patients with lung or thyroid cancer and highlights resources provided through her organization that support patients and health care professionals.

A ‘Turning Point’ for Metastatic NSCLC Treatment

June 22nd 2021, 6:00pm


Patients with metastatic KRAS G12C mutated non-small cell lung cancer now have another treatment option if they previously failed at least one line of therapy.

Less Is More in Lung Cancer Treatment

June 17th 2021, 1:00pm


Novel combo regimen reduces number of toxic treatments in patients with NSCLC.

Educating Patients About Biomarker Testing

June 16th 2021, 3:21pm


Common questions asked by patients with lung or thyroid cancer who have been referred for biomarker testing and advice for setting expectations from test results.

The Emerging Role of Liquid Biopsies

June 16th 2021, 3:15pm


Drs Benjamin Levy and Lori J. Wirth comment on the current role of liquid biopsies in lung and thyroid cancer.

Best Practices When Testing With Comprehensive Genomic Profiling

June 9th 2021, 2:45pm


Recommendations for selecting appropriate patients for comprehensive genomic profiling and navigating through the testing process.

Comprehensive Genomic Profiling in Lung and Thyroid Cancer

June 9th 2021, 2:35pm


Drs Benjamin Levy and Lori J. Wirth describe how they currently utilize comprehensive genomic profiling to manage patients with non–small cell lung cancer or thyroid cancer.